Certain Xanax extended release tablets distributed by Vitaris Specialty LLC have been recalled due to “failed dissolution specifications,” according to the U.S. Food and Drug Administration.
Alprazolam, a prescription medication used to treat anxiety and panic disorders, is in a class of medications called benzodiazepines, said the National Library pf Medicine. It is sold under the brand name Xanax XR by Vitaris.
A little over 9% of American adults (more than 21 million people) reported benzodiazepine use in 2023, said the University of Alabama at Birmingham Reporter in an article published last year. AARP explained in an October 2025 article about a separate recall that “failed dissolution specifications” refers to pills or tablets that do not break down at the right speed to be absorbed by the body after they are swallowed.
“If it dissolves too slowly or unevenly, you might not get the full benefit – even if you take the correct dose,” the AARP said.
Per the FDA, bottles of 60 count 3 milligram Xanax XR tablets that were made in Ireland are included in the voluntary recall. A product quantity was not listed by the FDA, though lot number 8177156 was included, along with a “02/28/2027” expiration date.
This recall is listed as “ongoing” by the FDA.
